Hypersensitivity
|
1 (2.6 %)
|
0 (0 %)
|
1
|
Peripheral sensory neuropathy
|
2 (5.3 %)
|
2 (13.3 %)
|
0.56
|
Hematological toxicities
|
5 (13.2 %)
|
3 (20 %)
|
0.67
|
Febrile neutropenia
|
1 (2.6 %)
|
1 (6.7 %)
|
0.49
|
Gastrointestinal toxicity
|
2 (5.3 %)
|
2 (13.3 %)
|
0.56
|
Skin toxicity (hand foot syndrome grade III)
|
0 (0 %)
|
1 (6.7 %)
|
0.28
|
Treatment discontinuation
|
3 (7.9 %)
|
4 (26.7 %)
|
0.09
|